All patients with pathogenic mutations in the SPAST gene exhibited progressive spastic paraparesis, with 8 patients, including the sporadic patient case, also experiencing bladder disturbances (66%) and 9 having mild or moderate degree of depression (75%). The gene discussed is SPAST; the disease is depressive symptom measurement.